FDA Focus: What Lowenstein's Practice Chair Is Watching
Lowenstein Sandler LLP's James Shehan, chair of the firm's U.S. Food and Drug Administration practice, tells Law360 he's tracking patent litigation over biosimilars, watching for new off-label promotion policies and eyeing...To view the full article, register now.
Already a subscriber? Click here to view full article